Tendee LogoChatBlog
Public Tender Opportunity

Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - RUXOLITINIB [15 MG; CÁP/ COMP]

Published on August 5, 2025

Tender Description

RUXOLITINIB [15 MG; CÁP/ COMP]

Unlock Full Tender Insight

Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.

It's free to get started. No credit card required.

Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - RUXOLITINIB [15 MG; CÁP/ COMP] | Public Tender | tend.ee